This new category encompasses the nine above-mentioned gene mutations (ASXL1, RUNX1, BCOR, EZH2, SF3B1, SRSF2, STAG2, U2AF1, ZRSR2) associated with AML arising from MDS. This evidence concerns the gene ASXL1 and myelodysplastic syndrome.